Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany

Felicitas Kühne, Katharina Achtert, Franziska Püschner, Dominika Urbanski-Rini, Juliane Schiller, Ernestine Mahar, Josephine Friedrich, Mark Atwood, Ralf Sprenger, Jeffrey Vietri, Christof von Eiff, Christian Theilacker
doi: https://doi.org/10.1101/2023.02.16.23286052

Article usage

Article usage: February 2023 to June 2025

AbstractFullPdf
Feb 2023342850
Mar 2023160560
Apr 2023104140
May 202344227
Jun 2023160947
Jul 2023100825
Aug 2023581721
Sep 202377828
Oct 2023621524
Nov 202350620
Dec 202321119
Jan 202416113
Feb 202434413
Mar 2024421224
Apr 202419118
May 20242028
Jun 20241468
Jul 202423417
Aug 202418616
Sep 20243244
Oct 20241525
Nov 20241914
Dec 202441115
Jan 202526418
Feb 2025306521
Mar 2025329221
Apr 2025222332
May 2025281741
Jun 20252878
Back to top
Posted June 19, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany
Felicitas Kühne, Katharina Achtert, Franziska Püschner, Dominika Urbanski-Rini, Juliane Schiller, Ernestine Mahar, Josephine Friedrich, Mark Atwood, Ralf Sprenger, Jeffrey Vietri, Christof von Eiff, Christian Theilacker
medRxiv 2023.02.16.23286052; doi: https://doi.org/10.1101/2023.02.16.23286052
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area